Sanofi, GlaxoSmithKline signs deal with Canada to deliver 72 million doses of potential COVID-19 vaccineMarket Watch • 09/22/20
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccineGlobeNewsWire • 09/22/20
GSK highlights scientific advances across its growing oncology portfolio at ESMO Virtual Congress 2020PRNewsWire • 09/15/20
FDA Approves Trelegy Ellipta as the First Once-Daily Single Inhaler Triple Therapy for the Treatment of Both Asthma and COPD in the USBusiness Wire • 09/09/20
GSK Consumer Healthcare Introduces the Biggest Innovation in the U.S. Over-The-Counter Oral Pain Relief Category in 25 Years: New Advil Dual Action with AcetaminophenPRNewsWire • 09/08/20
Nine biopharma CEOs pledge to make safety the main focus in coronavirus vaccine developmentCNBC • 09/08/20
Moderna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political PressureThe Motley Fool • 09/05/20
Better Late Than Never: Sanofi and GlaxoSmithKline Start Coronavirus Vaccine Clinical Trial ProgramThe Motley Fool • 09/03/20